Package 0009-7686-04

{"route": ["INTRACAVERNOUS"], "spl_id": "c9c81920-1b63-4318-9cc1-38cc4d3fa601", "openfda": {"nui": ["N0000009059", "N0000175454", "N0000180189", "N0000000106", "M0017805", "N0000009911"], "unii": ["F5TD010360"], "rxcui": ["103956", "226921", "226922", "242691"], "spl_set_id": ["a295fc1e-d82c-4f44-bc2d-a552bf594c98"], "pharm_class_cs": ["Prostaglandins [CS]"], "pharm_class_pe": ["Genitourinary Arterial Vasodilation [PE]", "Venous Vasodilation [PE]"], "pharm_class_epc": ["Prostaglandin Analog [EPC]", "Prostaglandin E1 Agonist [EPC]"], "pharm_class_moa": ["Prostaglandin Receptor Agonists [MoA]"], "manufacturer_name": ["Pharmacia & Upjohn Company LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-7686-04)  / 1 mL in 1 VIAL, SINGLE-DOSE (0009-7686-01)", "package_ndc": "0009-7686-04", "marketing_start_date": "19950706"}], "brand_name": "Caverject", "product_id": "0009-7686_c9c81920-1b63-4318-9cc1-38cc4d3fa601", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Genitourinary Arterial Vasodilation [PE]", "Prostaglandin Analog [EPC]", "Prostaglandin E1 Agonist [EPC]", "Prostaglandin Receptor Agonists [MoA]", "Prostaglandins [CS]", "Venous Vasodilation [PE]"], "product_ndc": "0009-7686", "generic_name": "Alprostadil", "labeler_name": "Pharmacia & Upjohn Company LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Caverject", "active_ingredients": [{"name": "ALPROSTADIL", "strength": "41.1 ug/mL"}], "application_number": "NDA020379", "marketing_category": "NDA", "marketing_start_date": "19950706", "listing_expiration_date": "20261231"}